Tenet Healthcare (NYSE:THC) Share Price Crosses Above 200-Day Moving Average – What’s Next?

Posted by George Bondi on Oct 15th, 2026

Tenet Healthcare Corporation (NYSE:THC – Get Free Report) shares passed above its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $217.61 and traded as high as $269.30. Tenet Healthcare shares last traded at $266.69, with a volume of 599,982 shares traded.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on THC shares. Barclays increased their price objective on shares of Tenet Healthcare from $240.00 to $271.00 and gave the company an “overweight” rating in a research note on Friday, July 24th. Mizuho set a $290.00 price objective on shares of Tenet Healthcare in a research note on Monday, August 10th. Zacks Research lowered Tenet Healthcare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 29th. Weiss Ratings raised Tenet Healthcare from a “buy (b-)” rating to a “buy (b)” rating in a research report on Thursday, October 8th. Finally, Wall Street Zen downgraded Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday, October 3rd. Eighteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, Tenet Healthcare presently has an average rating of “Moderate Buy” and a consensus target price of $277.25.

View Our Latest Stock Report on Tenet Healthcare

Tenet Healthcare Stock Performance

The company has a debt-to-equity ratio of 2.00, a current ratio of 1.41 and a quick ratio of 1.35. The firm has a market cap of $22.15 billion, a price-to-earnings ratio of 10.61, a P/E/G ratio of 1.02 and a beta of 1.20. The firm has a fifty day simple moving average of $263.90 and a two-hundred day simple moving average of $218.15.

Tenet Healthcare (NYSE:THC – Get Free Report) last posted its quarterly earnings data on Thursday, July 23rd. The company reported $6.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.26 by $1.86. The firm had revenue of $6.04 billion for the quarter, compared to the consensus estimate of $5.43 billion. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. The company’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $4.02 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. On average, analysts expect that Tenet Healthcare Corporation will post 21.04 EPS for the current year.

Insider Buying and Selling at Tenet Healthcare

In other news, Director Richard J. Mark sold 10,000 shares of the business’s stock in a transaction on Thursday, September 10th. The shares were sold at an average price of $263.42, for a total transaction of $2,634,200.00. Following the sale, the director directly owned 25,121 shares of the company’s stock, valued at $6,617,373.82. The trade was a 28.47% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Lisa Y. Foo sold 24,000 shares of the company’s stock in a transaction on Monday, August 31st. The shares were sold at an average price of $266.32, for a total value of $6,391,680.00. Following the completion of the transaction, the executive vice president directly owned 8,053 shares in the company, valued at approximately $2,144,674.96. The trade was a 74.88% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 131,199 shares of company stock worth $35,065,587 in the last three months. 0.97% of the stock is owned by company insiders.

Institutional Trading of Tenet Healthcare

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Manning & Napier Advisors LLC purchased a new stake in shares of Tenet Healthcare in the second quarter worth about $168,761,000. Arrowstreet Capital Limited Partnership grew its holdings in Tenet Healthcare by 57.4% during the first quarter. Arrowstreet Capital Limited Partnership now owns 671,700 shares of the company’s stock worth $126,757,000 after acquiring an additional 244,901 shares during the period. Bank of New York Mellon Corp purchased a new position in Tenet Healthcare during the second quarter valued at approximately $106,342,000. Empowered Funds LLC raised its position in Tenet Healthcare by 22.1% during the first quarter. Empowered Funds LLC now owns 284,753 shares of the company’s stock valued at $53,736,000 after acquiring an additional 51,549 shares in the last quarter. Finally, Hsbc Holdings PLC lifted its holdings in Tenet Healthcare by 3,478.7% in the fourth quarter. Hsbc Holdings PLC now owns 266,400 shares of the company’s stock valued at $53,269,000 after acquiring an additional 258,956 shares during the period. Institutional investors and hedge funds own 95.44% of the company’s stock.

About Tenet Healthcare

(Get Free Report)

Tenet Healthcare Corporation is a Dallas-based healthcare services company that operates hospitals, outpatient facilities and other healthcare businesses across the United States. Its operations include acute care hospitals, specialty hospitals, ambulatory surgery centers and related outpatient services.

Through its United Surgical Partners International subsidiary, Tenet is one of the major operators and developers of ambulatory surgery centers in the United States. These facilities provide same-day surgical procedures and other outpatient care across a range of medical specialties.